Skip to main content
SpringerLink
Log in

Bevacizumab increases risk of arterial thromboembolism and MI

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Ranpura V, Chuang J, Wu S.Increased Risk of Cardiac Ischemia and Arterial Thromboembolic Events in Cancer Patients Treated with Bevacizumab: A Meta-Analysis. 59th Annual Scientific Session of the American College of Cardiology: abstr. 1155-276, 14 Mar 2010. Available from: URL: http://www.abstractsonline.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab increases risk of arterial thromboembolism and MI. React. Wkly. 1299, 3 (2010). https://doi.org/10.2165/00128415-201012990-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012990-00006

Keywords

Search

Navigation